{"gene":"RIMS2","run_date":"2026-04-28T19:45:45","timeline":{"discoveries":[{"year":2001,"finding":"The cAMP-binding protein cAMP-GEFII (Epac2) interacts with RIM2 to mediate cAMP-dependent, PKA-independent exocytosis in pancreatic beta-cells; antisense knockdown of cAMP-GEFII combined with PKA inhibition inhibited incretin-potentiated insulin secretion by ~80-90%, establishing the cAMP-GEFII–RIM2 pathway as critical for incretin-potentiated insulin secretion.","method":"Antisense oligodeoxynucleotide knockdown in pancreatic islets, reconstituted exocytosis system, pharmacological inhibition (H-89)","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — reconstituted system plus native-cell antisense knockdown with defined functional readout (insulin secretion), replicated across conditions","pmids":["11598134"],"is_preprint":false},{"year":2002,"finding":"Piccolo, a CAZ protein, binds to cAMP-GEFII and forms Ca2+-dependent homodimers and heterodimers with RIM2 (Piccolo·RIM2 heterodimer being stronger than Piccolo·Piccolo homodimer); together these form a cAMP-GEFII·RIM2·Piccolo complex required for cAMP-induced insulin secretion, with Piccolo serving as the Ca2+ sensor in this complex.","method":"Co-immunoprecipitation, dimerization assays, antisense oligodeoxynucleotide knockdown of Piccolo in pancreatic islets","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — reciprocal binding assays plus functional antisense knockdown with defined secretion phenotype","pmids":["12401793"],"is_preprint":false},{"year":2003,"finding":"RIM2 interacts with Rab3A/B/C/D and Rab8A (but not Rab27A/B or Rab26/37, unlike RIM1); the acidic cluster Glu-50, Glu-51, Glu-52 in the first alpha-helical region (α1) of the RIM2 Rab-binding domain is a critical determinant of Rab3A recognition, as shown by site-directed mutagenesis and chimeric analysis.","method":"Cotransfection binding assay with 42 different Rab proteins, site-directed mutagenesis, chimeric protein analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — systematic mutagenesis with structure-function analysis, multiple Rab proteins tested","pmids":["12578829"],"is_preprint":false},{"year":2005,"finding":"Crystal structure of the RIM2 C2A-domain at 1.4 Å resolution reveals a beta-sandwich with a unique dipolar electrostatic charge distribution; NMR and biochemical assays show the domain does not bind Ca2+ (lacking full complement of aspartate residues) and shows little binding to SNAP-25 or synaptotagmin 1 C2-domains, suggesting Ca2+-independent interactions via its bottom face mediate function.","method":"X-ray crystallography (1.4 Å), NMR spectroscopy, Ca2+-binding assays, protein-protein interaction assays","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 — crystal structure with NMR validation and biochemical binding assays","pmids":["16216076"],"is_preprint":false},{"year":2005,"finding":"The short forms of RIM2 Rab-binding domain (RBD) interact with Rab3A with high affinity in vitro and are recruited to dense-core vesicles (DCVs) in neuroendocrine PC12 cells via endogenous Rab3A; the long forms show >50-fold reduced Rab3A-binding activity and remain cytoplasmic/nuclear. Expression of the shortest RIM2 RBD (but not Rab3A-binding-defective mutant E36A/R37S) promotes high-KCl-dependent neuropeptide Y secretion from PC12 cells.","method":"In vitro binding assay, subcellular localization (PC12 cells), DCV fractionation, neuropeptide Y secretion assay, site-directed mutagenesis","journal":"Methods in enzymology","confidence":"High","confidence_rationale":"Tier 1-2 — in vitro binding with mutagenesis plus cell-based localization and functional secretion assay","pmids":["16473611"],"is_preprint":false},{"year":2009,"finding":"Flavivirus TBEV-NS5 protein binds RIMS2 via an internal PDZ-binding mechanism with high affinity; this interaction stabilizes TBEV-NS5 targeting to the plasma membrane.","method":"Protein-protein interaction assays, co-localization imaging","journal":"Biological chemistry","confidence":"Medium","confidence_rationale":"Tier 3 — single study binding and co-localization without rigorous functional epistasis","pmids":["19199833"],"is_preprint":false},{"year":2011,"finding":"GLP-1 enhances glucokinase (GK) activity in pancreatic beta-cells via a cAMP-dependent, PKA-independent pathway involving Epac2, RIM2, and Rab3A; silencing RIM2 (or Epac2 or Rab3A) blocks the GLP-1-induced increase in GK activity, cellular glucose uptake, mitochondrial membrane potential, and ATP levels.","method":"RNAi knockdown (siRNA silencing) of RIM2/Epac2/Rab3A in INS-1 cells and native beta-cells, glucokinase activity assay, mitochondrial membrane potential measurement","journal":"Endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 — knockdown with multiple biochemical readouts, but single lab","pmids":["22147008"],"is_preprint":false},{"year":2012,"finding":"Super-resolution STED microscopy of zebrafish photoreceptors shows RIM2 is localized inside the horseshoe-shaped synaptic ribbon structure (with RIBEYE on the outside), and CaV1.4 (CACNA1F) clusters beneath RIM2/RIBEYE; RIBEYE morpholino knockdown reduces ribbon number/length, reduces RIM2 expression, and abolishes CaV1.4 clustering, demonstrating RIM2 depends on RIBEYE for its synaptic ribbon localization.","method":"STED super-resolution microscopy, morpholino antisense knockdown of RIBEYE in zebrafish, immunostaining","journal":"Microscopy and microanalysis","confidence":"Medium","confidence_rationale":"Tier 2 — direct super-resolution localization with functional knockdown consequence","pmids":["22832038"],"is_preprint":false},{"year":2014,"finding":"RIM1 and RIM2 redundantly determine presynaptic Ca2+ channel density and readily releasable pool (RRP) size at the calyx of Held synapse; conditional RIM2 KO alone causes a subtle reduction in Ca2+ current density, while RIM1 single KO is ineffective; RIM1/2 double KO strongly reduces both Ca2+ channel density and RRP, demonstrating functional redundancy between the two RIM isoforms at this synapse.","method":"Conditional genetic knockout (single and double) in mice, direct presynaptic electrophysiology at calyx of Held, quantitative PCR","journal":"Journal of neurophysiology","confidence":"High","confidence_rationale":"Tier 2 — clean conditional KO with direct electrophysiological readout; epistatic double-KO comparison","pmids":["25343783"],"is_preprint":false},{"year":2020,"finding":"Loss-of-function biallelic RIMS2 variants cause a syndromic congenital cone-rod synaptic disorder (CRSD) with neurodevelopmental disease and abnormal glucose homeostasis; RIMS2 localizes to the human retinal outer plexiform layer, Purkinje cells, and pancreatic islets; nonsense RIMS2 variants produce truncated protein and decrease insulin secretion in mammalian cells.","method":"Human genetics (biallelic variants), immunostaining for RIMS2 localization, mammalian cell expression of truncated RIMS2 with insulin secretion assay","journal":"American journal of human genetics","confidence":"Medium","confidence_rationale":"Tier 2 — loss-of-function human genetics with direct subcellular localization and functional insulin secretion assay","pmids":["32470375"],"is_preprint":false},{"year":2020,"finding":"Synaptic ribbons are required to stabilize RIM2 (and CaV1.4) at rod photoreceptor active zones and for darkness-induced enrichment of RIM2/CaV1.4 clusters; in RIBEYE knockout mice, RIM2 and CaV1.4 active zone clusters are destabilized and fail to enlarge during dark-adaptation.","method":"Analysis of RIBEYE knockout mice, immunostaining, quantitative measurement of ribbon length and RIM2/CaV1.4 cluster length","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 — genetic KO mouse model with direct quantitative localization analysis","pmids":["32249787"],"is_preprint":false},{"year":2024,"finding":"RBM5 (RNA binding motif 5) regulates RIMS2 splicing/protein homeostasis in the brain; RBM5 conditional KO in mice increases a novel ~170 kDa RIMS2 variant in hippocampus and decreases canonical RIMS2 in cerebellum and hippocampus, linking RBM5-dependent splicing to RIMS2 isoform regulation.","method":"Conditional gene knockout in mice, immunoprecipitation, western blot","journal":"Experimental neurology","confidence":"Low","confidence_rationale":"Tier 3 — single study, western blot/IP only, no direct splicing mechanism validated","pmids":["38218585"],"is_preprint":false}],"current_model":"RIMS2 is a large presynaptic active zone scaffolding protein that functions as a Rab3A/8A effector (binding through its N-terminal RBD domain, with Glu-50/51/52 critical for Rab3A recognition), forms a cAMP-GEFII (Epac2)·RIM2·Piccolo complex to mediate PKA-independent, Ca2+-dependent secretory vesicle exocytosis, redundantly controls presynaptic Ca2+ channel density and readily releasable pool size with RIM1, is stabilized at ribbon synaptic active zones by RIBEYE, and its C2A domain adopts a Ca2+-independent beta-sandwich fold that likely functions through electrostatic protein-protein interactions at its bottom face."},"narrative":{"teleology":[{"year":2001,"claim":"The discovery that cAMP-GEFII (Epac2) partners with RIM2 to drive PKA-independent exocytosis in β-cells established the first signaling pathway through which RIM2 acts, revealing it as more than a structural scaffold — it is a functional node in incretin-potentiated insulin secretion.","evidence":"Antisense knockdown of cAMP-GEFII in pancreatic islets combined with PKA inhibition, reconstituted exocytosis system","pmids":["11598134"],"confidence":"High","gaps":["Direct binding interface between Epac2 and RIM2 not mapped","Contribution of individual RIM2 domains to this pathway unknown"]},{"year":2002,"claim":"Identification of the trimeric cAMP-GEFII·RIM2·Piccolo complex, with Piccolo as Ca²⁺ sensor, resolved how Ca²⁺ sensitivity is conferred on a cAMP-driven exocytotic pathway lacking direct Ca²⁺ binding by RIM2 itself.","evidence":"Co-immunoprecipitation, dimerization assays, antisense knockdown of Piccolo in pancreatic islets","pmids":["12401793"],"confidence":"High","gaps":["Stoichiometry and assembly order of the tripartite complex undefined","Whether this complex operates at neuronal synapses unknown"]},{"year":2003,"claim":"Systematic Rab-specificity mapping and mutagenesis of the RIM2 RBD identified Glu-50/51/52 as critical for Rab3A recognition and showed RIM2 differs from RIM1 in not binding Rab27A, establishing isoform-specific effector selectivity.","evidence":"Cotransfection binding assay with 42 Rab proteins, site-directed mutagenesis, chimeric analysis","pmids":["12578829"],"confidence":"High","gaps":["No crystal structure of RIM2-RBD·Rab3A complex","Functional consequence of Rab8A interaction uncharacterized"]},{"year":2005,"claim":"The 1.4 Å crystal structure of the RIM2 C2A domain revealed it does not bind Ca²⁺ and possesses a unique dipolar electrostatic surface, redefining it as a Ca²⁺-independent protein–protein interaction module rather than a classical Ca²⁺ sensor.","evidence":"X-ray crystallography, NMR spectroscopy, Ca²⁺-binding and protein-protein interaction assays","pmids":["16216076"],"confidence":"High","gaps":["Physiological binding partners of the C2A bottom face not identified","Whether C2B domain similarly lacks Ca²⁺ binding untested"]},{"year":2005,"claim":"Demonstrating that short RIM2-RBD isoforms are recruited to dense-core vesicles via Rab3A and promote regulated secretion, while long isoforms with reduced Rab3A affinity do not, linked Rab3A-binding capacity directly to vesicle targeting and exocytosis.","evidence":"In vitro binding, subcellular localization in PC12 cells, neuropeptide Y secretion assay with binding-defective mutant","pmids":["16473611"],"confidence":"High","gaps":["Mechanism of long-form autoinhibition not structurally resolved","Whether isoform switching is physiologically regulated unknown"]},{"year":2011,"claim":"Placing RIM2 within the GLP-1→cAMP→Epac2→RIM2→Rab3A cascade that enhances glucokinase activity extended its role beyond vesicle fusion to metabolic amplification of insulin secretion.","evidence":"RNAi knockdown of RIM2, Epac2, Rab3A in INS-1 and native β-cells with glucokinase activity and mitochondrial readouts","pmids":["22147008"],"confidence":"Medium","gaps":["Mechanism by which vesicle-associated RIM2 regulates cytoplasmic glucokinase unclear","Single-lab finding not independently replicated"]},{"year":2012,"claim":"Super-resolution imaging placed RIM2 inside the synaptic ribbon and CaV1.4 beneath it, and showed RIBEYE knockdown destabilizes RIM2, establishing the first spatial model of ribbon active zone architecture with RIM2 as an intermediary between RIBEYE and Ca²⁺ channels.","evidence":"STED microscopy and RIBEYE morpholino knockdown in zebrafish photoreceptors","pmids":["22832038"],"confidence":"Medium","gaps":["Direct binding interface between RIBEYE and RIM2 not mapped","Whether this architecture is conserved across vertebrate ribbon synapses unknown"]},{"year":2014,"claim":"Conditional double knockout of RIM1 and RIM2 at the calyx of Held quantitatively demonstrated their functional redundancy in maintaining presynaptic Ca²⁺ channel density and readily releasable pool size, establishing that neither isoform alone is essential at this synapse.","evidence":"Single and double conditional KO in mice with direct presynaptic patch-clamp electrophysiology at calyx of Held","pmids":["25343783"],"confidence":"High","gaps":["Molecular mechanism of Ca²⁺ channel tethering by RIMs not resolved","Whether redundancy holds at smaller CNS boutons untested"]},{"year":2020,"claim":"Convergent studies in RIBEYE KO mice and human patients with biallelic RIMS2 loss-of-function variants established that RIBEYE stabilizes RIM2/CaV1.4 at photoreceptor active zones and that RIMS2 loss causes congenital cone-rod synaptic disorder with neurodevelopmental and metabolic phenotypes, validating its essential role in vivo across tissues.","evidence":"RIBEYE KO mice with quantitative immunostaining; human genetic study with biallelic variants, RIMS2 localization in human retina/cerebellum/islets, insulin secretion assay with truncated RIMS2","pmids":["32249787","32470375"],"confidence":"Medium","gaps":["Genotype–phenotype correlation across different RIMS2 variants limited","Whether partial loss-of-function alleles cause milder disease unknown","Rescue experiments not performed"]},{"year":2024,"claim":"RBM5 was identified as a trans-acting regulator of RIMS2 splicing and protein homeostasis, revealing a new upstream layer controlling RIMS2 isoform diversity in brain.","evidence":"Conditional RBM5 KO in mice with immunoprecipitation and western blot analysis of RIMS2 variants","pmids":["38218585"],"confidence":"Low","gaps":["Direct splicing mechanism and target exons not validated","Not independently confirmed","Functional consequence of the novel ~170 kDa RIMS2 variant unknown"]},{"year":null,"claim":"Key unresolved questions include the structural basis of RIM2 interactions with RIBEYE and Ca²⁺ channels, the mechanism by which the C2A domain's electrostatic surface recruits specific partners, and whether distinct RIMS2 splice variants serve non-redundant roles at different synapse types.","evidence":"","pmids":[],"confidence":"Low","gaps":["No structure of RIM2 in complex with RIBEYE or CaV channels","C2A physiological partners unidentified","Isoform-specific functions at distinct synapse types not dissected"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[0,1,2,4,8]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[4,7]},{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[4]}],"pathway":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[4]}],"complexes":["cAMP-GEFII (Epac2)·RIM2·Piccolo complex"],"partners":["RAPGEF4","PCLO","RAB3A","RAB8A","RIBEYE","CACNA1F","RIM1"],"other_free_text":[]},"mechanistic_narrative":"RIMS2 is a presynaptic active zone scaffolding protein that functions as a Rab3A effector to regulate Ca²⁺-dependent exocytosis at both neuronal synapses and neuroendocrine secretory sites. Its N-terminal Rab-binding domain recognizes Rab3A through a critical acidic cluster (Glu-50/51/52), and its C2A domain adopts a Ca²⁺-independent β-sandwich fold with a dipolar electrostatic surface mediating protein–protein interactions [PMID:12578829, PMID:16216076]. In pancreatic β-cells, RIMS2 forms a cAMP-GEFII (Epac2)·RIM2·Piccolo complex that mediates cAMP-dependent, PKA-independent insulin secretion potentiated by incretins, with Piccolo serving as the Ca²⁺ sensor [PMID:11598134, PMID:12401793]. At neuronal synapses, RIMS2 redundantly controls presynaptic Ca²⁺ channel density and readily releasable pool size with RIM1, and at photoreceptor ribbon synapses it is stabilized by RIBEYE to organize CaV1.4 channel clusters; biallelic loss-of-function RIMS2 variants cause a syndromic congenital cone-rod synaptic disorder with neurodevelopmental impairment and abnormal glucose homeostasis [PMID:25343783, PMID:32249787, PMID:32470375]."},"prefetch_data":{"uniprot":{"accession":"Q9UQ26","full_name":"Regulating synaptic membrane exocytosis protein 2","aliases":["Rab-3-interacting molecule 2","RIM 2","Rab-3-interacting protein 3"],"length_aa":1411,"mass_kda":160.4,"function":"Rab effector involved in exocytosis. May act as scaffold protein. Plays a role in dendrite formation by melanocytes (PubMed:23999003)","subcellular_location":"Cell membrane; Synapse; Presynaptic cell membrane","url":"https://www.uniprot.org/uniprotkb/Q9UQ26/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/RIMS2","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/RIMS2","total_profiled":1310},"omim":[{"mim_id":"618970","title":"CONE-ROD SYNAPTIC DISORDER SYNDROME, CONGENITAL NONPROGRESSIVE; CRSDS","url":"https://www.omim.org/entry/618970"},{"mim_id":"611602","title":"RIMS-BINDING PROTEIN 2; RIMBP2","url":"https://www.omim.org/entry/611602"},{"mim_id":"611600","title":"PROTEIN REGULATING SYNAPTIC MEMBRANE EXOCYTOSIS 3; RIMS3","url":"https://www.omim.org/entry/611600"},{"mim_id":"610764","title":"TSPO-ASSOCIATED PROTEIN 1; TSPOAP1","url":"https://www.omim.org/entry/610764"},{"mim_id":"610427","title":"CONE-ROD SYNAPTIC DISORDER, CONGENITAL NONPROGRESSIVE; CRSD","url":"https://www.omim.org/entry/610427"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Plasma membrane","reliability":"Approved"},{"location":"Cytosol","reliability":"Approved"}],"tissue_specificity":"Group enriched","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"adrenal gland","ntpm":45.5},{"tissue":"brain","ntpm":41.6},{"tissue":"retina","ntpm":72.6}],"url":"https://www.proteinatlas.org/search/RIMS2"},"hgnc":{"alias_symbol":["KIAA0751","RIM2","OBOE"],"prev_symbol":["RAB3IP3"]},"alphafold":{"accession":"Q9UQ26","domains":[{"cath_id":"3.30.60.120","chopping":"121-178","consensus_level":"medium","plddt":83.9271,"start":121,"end":178},{"cath_id":"2.30.42.10","chopping":"647-667_674-756","consensus_level":"high","plddt":83.63,"start":647,"end":756},{"cath_id":"2.60.40.150","chopping":"807-938","consensus_level":"high","plddt":89.0684,"start":807,"end":938},{"cath_id":"2.60.40.150","chopping":"1240-1389","consensus_level":"high","plddt":89.4809,"start":1240,"end":1389}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9UQ26","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UQ26-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UQ26-F1-predicted_aligned_error_v6.png","plddt_mean":54.5},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=RIMS2","jax_strain_url":"https://www.jax.org/strain/search?query=RIMS2"},"sequence":{"accession":"Q9UQ26","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9UQ26.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9UQ26/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9UQ26"}},"corpus_meta":[{"pmid":"11598134","id":"PMC_11598134","title":"Critical role of cAMP-GEFII--Rim2 complex in incretin-potentiated insulin secretion.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11598134","citation_count":289,"is_preprint":false},{"pmid":"12401793","id":"PMC_12401793","title":"Piccolo, a Ca2+ sensor in pancreatic beta-cells. Involvement of cAMP-GEFII.Rim2. Piccolo complex in cAMP-dependent exocytosis.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12401793","citation_count":166,"is_preprint":false},{"pmid":"12578829","id":"PMC_12578829","title":"Distinct Rab binding specificity of Rim1, Rim2, rabphilin, and Noc2. Identification of a critical determinant of Rab3A/Rab27A recognition by Rim2.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12578829","citation_count":159,"is_preprint":false},{"pmid":"22147008","id":"PMC_22147008","title":"Glucagon-like peptide-1 enhances glucokinase activity in pancreatic β-cells through the association of Epac2 with Rim2 and Rab3A.","date":"2011","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/22147008","citation_count":43,"is_preprint":false},{"pmid":"21777202","id":"PMC_21777202","title":"Rim2, a pyrimidine nucleotide exchanger, is needed for iron utilization in mitochondria.","date":"2011","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/21777202","citation_count":38,"is_preprint":false},{"pmid":"25343783","id":"PMC_25343783","title":"RIM1 and RIM2 redundantly determine Ca2+ channel density and readily releasable pool size at a large hindbrain synapse.","date":"2014","source":"Journal of neurophysiology","url":"https://pubmed.ncbi.nlm.nih.gov/25343783","citation_count":35,"is_preprint":false},{"pmid":"19199833","id":"PMC_19199833","title":"Flavivirus NS5 associates with host-cell proteins zonula occludens-1 (ZO-1) and regulating synaptic membrane exocytosis-2 (RIMS2) via an internal PDZ binding mechanism.","date":"2009","source":"Biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19199833","citation_count":33,"is_preprint":false},{"pmid":"32249787","id":"PMC_32249787","title":"Synaptic ribbons foster active zone stability and illumination-dependent active zone enrichment of RIM2 and Cav1.4 in photoreceptor synapses.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/32249787","citation_count":32,"is_preprint":false},{"pmid":"23800229","id":"PMC_23800229","title":"The mitochondrial carrier Rim2 co-imports pyrimidine nucleotides and iron.","date":"2013","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/23800229","citation_count":32,"is_preprint":false},{"pmid":"11016827","id":"PMC_11016827","title":"The rice Rim2 transcript accumulates in response to Magnaporthe grisea and its predicted protein product shares similarity with TNP2-like proteins encoded by CACTA transposons.","date":"2000","source":"Molecular & general genetics : MGG","url":"https://pubmed.ncbi.nlm.nih.gov/11016827","citation_count":28,"is_preprint":false},{"pmid":"22832038","id":"PMC_22832038","title":"High-resolution optical imaging of zebrafish larval ribbon synapse protein RIBEYE, RIM2, and CaV 1.4 by stimulation emission depletion microscopy.","date":"2012","source":"Microscopy and microanalysis : the official journal of Microscopy Society of America, Microbeam Analysis Society, Microscopical Society of Canada","url":"https://pubmed.ncbi.nlm.nih.gov/22832038","citation_count":27,"is_preprint":false},{"pmid":"14513364","id":"PMC_14513364","title":"Genomic characterization of Rim2/Hipa elements reveals a CACTA-like transposon superfamily with unique features in the rice genome.","date":"2003","source":"Molecular genetics and genomics : MGG","url":"https://pubmed.ncbi.nlm.nih.gov/14513364","citation_count":26,"is_preprint":false},{"pmid":"32470375","id":"PMC_32470375","title":"Loss of Function of RIMS2 Causes a Syndromic Congenital Cone-Rod Synaptic Disease with Neurodevelopmental and Pancreatic Involvement.","date":"2020","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/32470375","citation_count":21,"is_preprint":false},{"pmid":"8346681","id":"PMC_8346681","title":"RIM2, MSI1 and PGI1 are located within an 8 kb segment of Saccharomyces cerevisiae chromosome II, which also contains the putative ribosomal gene L21 and a new putative essential gene with a leucine zipper motif.","date":"1993","source":"Yeast (Chichester, England)","url":"https://pubmed.ncbi.nlm.nih.gov/8346681","citation_count":21,"is_preprint":false},{"pmid":"16216076","id":"PMC_16216076","title":"Crystal structure of the RIM2 C2A-domain at 1.4 A resolution.","date":"2005","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16216076","citation_count":18,"is_preprint":false},{"pmid":"30660752","id":"PMC_30660752","title":"Splitting the functions of Rim2, a mitochondrial iron/pyrimidine carrier.","date":"2019","source":"Mitochondrion","url":"https://pubmed.ncbi.nlm.nih.gov/30660752","citation_count":9,"is_preprint":false},{"pmid":"34738746","id":"PMC_34738746","title":"Circular Rims2 Deficiency Causes Retinal Degeneration.","date":"2021","source":"Advanced biology","url":"https://pubmed.ncbi.nlm.nih.gov/34738746","citation_count":7,"is_preprint":false},{"pmid":"16473611","id":"PMC_16473611","title":"Assay and functional interactions of Rim2 with Rab3.","date":"2005","source":"Methods in enzymology","url":"https://pubmed.ncbi.nlm.nih.gov/16473611","citation_count":5,"is_preprint":false},{"pmid":"9434937","id":"PMC_9434937","title":"rim2 (recombination-induced mutation 2) is a new allele of pearl and a mouse model of human Hermansky-Pudlak syndrome (HPS): genetic and physical mapping.","date":"1998","source":"Mammalian genome : official journal of the International Mammalian Genome Society","url":"https://pubmed.ncbi.nlm.nih.gov/9434937","citation_count":5,"is_preprint":false},{"pmid":"38468396","id":"PMC_38468396","title":"Autozygome-guided exome-first study in a consanguineous cohort with early-onset retinal disease uncovers an isolated RIMS2 phenotype and a retina-enriched RIMS2 isoform.","date":"2024","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/38468396","citation_count":4,"is_preprint":false},{"pmid":"38218585","id":"PMC_38218585","title":"Gene knockout of RNA binding motif 5 in the brain alters RIMS2 protein homeostasis in the cerebellum and Hippocampus and exacerbates behavioral deficits after a TBI in mice.","date":"2024","source":"Experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/38218585","citation_count":2,"is_preprint":false},{"pmid":"40819013","id":"PMC_40819013","title":"Genetic Heterogeneity of Autism Spectrum Disorder: Identification of Five Novel Mutations (RIMS2, FOXG1, AUTS2, ZCCHC17, and SPTBN5) in Iranian Families via Whole-Exome and Whole-Genome Sequencing.","date":"2025","source":"Biochemical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/40819013","citation_count":1,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2024.09.18.24313851","title":"Associations between RetNet gene polymorphisms and efficacy of orthokeratology for myopia control : sample from a clinical retrospective study","date":"2024-09-19","source":"bioRxiv","url":"https://doi.org/10.1101/2024.09.18.24313851","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":13126,"output_tokens":3084,"usd":0.042819},"stage2":{"model":"claude-opus-4-6","input_tokens":6463,"output_tokens":5560,"usd":0.256972},"total_usd":0.299791,"stage1_batch_id":"msgbatch_01SUR8NDzVrNmyszWyJeCct7","stage2_batch_id":"msgbatch_01G7Yfutko3cDWzejrwH5AMx","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2001,\n      \"finding\": \"The cAMP-binding protein cAMP-GEFII (Epac2) interacts with RIM2 to mediate cAMP-dependent, PKA-independent exocytosis in pancreatic beta-cells; antisense knockdown of cAMP-GEFII combined with PKA inhibition inhibited incretin-potentiated insulin secretion by ~80-90%, establishing the cAMP-GEFII–RIM2 pathway as critical for incretin-potentiated insulin secretion.\",\n      \"method\": \"Antisense oligodeoxynucleotide knockdown in pancreatic islets, reconstituted exocytosis system, pharmacological inhibition (H-89)\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reconstituted system plus native-cell antisense knockdown with defined functional readout (insulin secretion), replicated across conditions\",\n      \"pmids\": [\"11598134\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Piccolo, a CAZ protein, binds to cAMP-GEFII and forms Ca2+-dependent homodimers and heterodimers with RIM2 (Piccolo·RIM2 heterodimer being stronger than Piccolo·Piccolo homodimer); together these form a cAMP-GEFII·RIM2·Piccolo complex required for cAMP-induced insulin secretion, with Piccolo serving as the Ca2+ sensor in this complex.\",\n      \"method\": \"Co-immunoprecipitation, dimerization assays, antisense oligodeoxynucleotide knockdown of Piccolo in pancreatic islets\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal binding assays plus functional antisense knockdown with defined secretion phenotype\",\n      \"pmids\": [\"12401793\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"RIM2 interacts with Rab3A/B/C/D and Rab8A (but not Rab27A/B or Rab26/37, unlike RIM1); the acidic cluster Glu-50, Glu-51, Glu-52 in the first alpha-helical region (α1) of the RIM2 Rab-binding domain is a critical determinant of Rab3A recognition, as shown by site-directed mutagenesis and chimeric analysis.\",\n      \"method\": \"Cotransfection binding assay with 42 different Rab proteins, site-directed mutagenesis, chimeric protein analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — systematic mutagenesis with structure-function analysis, multiple Rab proteins tested\",\n      \"pmids\": [\"12578829\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Crystal structure of the RIM2 C2A-domain at 1.4 Å resolution reveals a beta-sandwich with a unique dipolar electrostatic charge distribution; NMR and biochemical assays show the domain does not bind Ca2+ (lacking full complement of aspartate residues) and shows little binding to SNAP-25 or synaptotagmin 1 C2-domains, suggesting Ca2+-independent interactions via its bottom face mediate function.\",\n      \"method\": \"X-ray crystallography (1.4 Å), NMR spectroscopy, Ca2+-binding assays, protein-protein interaction assays\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure with NMR validation and biochemical binding assays\",\n      \"pmids\": [\"16216076\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"The short forms of RIM2 Rab-binding domain (RBD) interact with Rab3A with high affinity in vitro and are recruited to dense-core vesicles (DCVs) in neuroendocrine PC12 cells via endogenous Rab3A; the long forms show >50-fold reduced Rab3A-binding activity and remain cytoplasmic/nuclear. Expression of the shortest RIM2 RBD (but not Rab3A-binding-defective mutant E36A/R37S) promotes high-KCl-dependent neuropeptide Y secretion from PC12 cells.\",\n      \"method\": \"In vitro binding assay, subcellular localization (PC12 cells), DCV fractionation, neuropeptide Y secretion assay, site-directed mutagenesis\",\n      \"journal\": \"Methods in enzymology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro binding with mutagenesis plus cell-based localization and functional secretion assay\",\n      \"pmids\": [\"16473611\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Flavivirus TBEV-NS5 protein binds RIMS2 via an internal PDZ-binding mechanism with high affinity; this interaction stabilizes TBEV-NS5 targeting to the plasma membrane.\",\n      \"method\": \"Protein-protein interaction assays, co-localization imaging\",\n      \"journal\": \"Biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single study binding and co-localization without rigorous functional epistasis\",\n      \"pmids\": [\"19199833\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"GLP-1 enhances glucokinase (GK) activity in pancreatic beta-cells via a cAMP-dependent, PKA-independent pathway involving Epac2, RIM2, and Rab3A; silencing RIM2 (or Epac2 or Rab3A) blocks the GLP-1-induced increase in GK activity, cellular glucose uptake, mitochondrial membrane potential, and ATP levels.\",\n      \"method\": \"RNAi knockdown (siRNA silencing) of RIM2/Epac2/Rab3A in INS-1 cells and native beta-cells, glucokinase activity assay, mitochondrial membrane potential measurement\",\n      \"journal\": \"Endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — knockdown with multiple biochemical readouts, but single lab\",\n      \"pmids\": [\"22147008\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Super-resolution STED microscopy of zebrafish photoreceptors shows RIM2 is localized inside the horseshoe-shaped synaptic ribbon structure (with RIBEYE on the outside), and CaV1.4 (CACNA1F) clusters beneath RIM2/RIBEYE; RIBEYE morpholino knockdown reduces ribbon number/length, reduces RIM2 expression, and abolishes CaV1.4 clustering, demonstrating RIM2 depends on RIBEYE for its synaptic ribbon localization.\",\n      \"method\": \"STED super-resolution microscopy, morpholino antisense knockdown of RIBEYE in zebrafish, immunostaining\",\n      \"journal\": \"Microscopy and microanalysis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct super-resolution localization with functional knockdown consequence\",\n      \"pmids\": [\"22832038\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"RIM1 and RIM2 redundantly determine presynaptic Ca2+ channel density and readily releasable pool (RRP) size at the calyx of Held synapse; conditional RIM2 KO alone causes a subtle reduction in Ca2+ current density, while RIM1 single KO is ineffective; RIM1/2 double KO strongly reduces both Ca2+ channel density and RRP, demonstrating functional redundancy between the two RIM isoforms at this synapse.\",\n      \"method\": \"Conditional genetic knockout (single and double) in mice, direct presynaptic electrophysiology at calyx of Held, quantitative PCR\",\n      \"journal\": \"Journal of neurophysiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean conditional KO with direct electrophysiological readout; epistatic double-KO comparison\",\n      \"pmids\": [\"25343783\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Loss-of-function biallelic RIMS2 variants cause a syndromic congenital cone-rod synaptic disorder (CRSD) with neurodevelopmental disease and abnormal glucose homeostasis; RIMS2 localizes to the human retinal outer plexiform layer, Purkinje cells, and pancreatic islets; nonsense RIMS2 variants produce truncated protein and decrease insulin secretion in mammalian cells.\",\n      \"method\": \"Human genetics (biallelic variants), immunostaining for RIMS2 localization, mammalian cell expression of truncated RIMS2 with insulin secretion assay\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function human genetics with direct subcellular localization and functional insulin secretion assay\",\n      \"pmids\": [\"32470375\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Synaptic ribbons are required to stabilize RIM2 (and CaV1.4) at rod photoreceptor active zones and for darkness-induced enrichment of RIM2/CaV1.4 clusters; in RIBEYE knockout mice, RIM2 and CaV1.4 active zone clusters are destabilized and fail to enlarge during dark-adaptation.\",\n      \"method\": \"Analysis of RIBEYE knockout mice, immunostaining, quantitative measurement of ribbon length and RIM2/CaV1.4 cluster length\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO mouse model with direct quantitative localization analysis\",\n      \"pmids\": [\"32249787\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"RBM5 (RNA binding motif 5) regulates RIMS2 splicing/protein homeostasis in the brain; RBM5 conditional KO in mice increases a novel ~170 kDa RIMS2 variant in hippocampus and decreases canonical RIMS2 in cerebellum and hippocampus, linking RBM5-dependent splicing to RIMS2 isoform regulation.\",\n      \"method\": \"Conditional gene knockout in mice, immunoprecipitation, western blot\",\n      \"journal\": \"Experimental neurology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single study, western blot/IP only, no direct splicing mechanism validated\",\n      \"pmids\": [\"38218585\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"RIMS2 is a large presynaptic active zone scaffolding protein that functions as a Rab3A/8A effector (binding through its N-terminal RBD domain, with Glu-50/51/52 critical for Rab3A recognition), forms a cAMP-GEFII (Epac2)·RIM2·Piccolo complex to mediate PKA-independent, Ca2+-dependent secretory vesicle exocytosis, redundantly controls presynaptic Ca2+ channel density and readily releasable pool size with RIM1, is stabilized at ribbon synaptic active zones by RIBEYE, and its C2A domain adopts a Ca2+-independent beta-sandwich fold that likely functions through electrostatic protein-protein interactions at its bottom face.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"RIMS2 is a presynaptic active zone scaffolding protein that functions as a Rab3A effector to regulate Ca²⁺-dependent exocytosis at both neuronal synapses and neuroendocrine secretory sites. Its N-terminal Rab-binding domain recognizes Rab3A through a critical acidic cluster (Glu-50/51/52), and its C2A domain adopts a Ca²⁺-independent β-sandwich fold with a dipolar electrostatic surface mediating protein–protein interactions [PMID:12578829, PMID:16216076]. In pancreatic β-cells, RIMS2 forms a cAMP-GEFII (Epac2)·RIM2·Piccolo complex that mediates cAMP-dependent, PKA-independent insulin secretion potentiated by incretins, with Piccolo serving as the Ca²⁺ sensor [PMID:11598134, PMID:12401793]. At neuronal synapses, RIMS2 redundantly controls presynaptic Ca²⁺ channel density and readily releasable pool size with RIM1, and at photoreceptor ribbon synapses it is stabilized by RIBEYE to organize CaV1.4 channel clusters; biallelic loss-of-function RIMS2 variants cause a syndromic congenital cone-rod synaptic disorder with neurodevelopmental impairment and abnormal glucose homeostasis [PMID:25343783, PMID:32249787, PMID:32470375].\",\n  \"teleology\": [\n    {\n      \"year\": 2001,\n      \"claim\": \"The discovery that cAMP-GEFII (Epac2) partners with RIM2 to drive PKA-independent exocytosis in β-cells established the first signaling pathway through which RIM2 acts, revealing it as more than a structural scaffold — it is a functional node in incretin-potentiated insulin secretion.\",\n      \"evidence\": \"Antisense knockdown of cAMP-GEFII in pancreatic islets combined with PKA inhibition, reconstituted exocytosis system\",\n      \"pmids\": [\"11598134\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct binding interface between Epac2 and RIM2 not mapped\", \"Contribution of individual RIM2 domains to this pathway unknown\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Identification of the trimeric cAMP-GEFII·RIM2·Piccolo complex, with Piccolo as Ca²⁺ sensor, resolved how Ca²⁺ sensitivity is conferred on a cAMP-driven exocytotic pathway lacking direct Ca²⁺ binding by RIM2 itself.\",\n      \"evidence\": \"Co-immunoprecipitation, dimerization assays, antisense knockdown of Piccolo in pancreatic islets\",\n      \"pmids\": [\"12401793\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry and assembly order of the tripartite complex undefined\", \"Whether this complex operates at neuronal synapses unknown\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Systematic Rab-specificity mapping and mutagenesis of the RIM2 RBD identified Glu-50/51/52 as critical for Rab3A recognition and showed RIM2 differs from RIM1 in not binding Rab27A, establishing isoform-specific effector selectivity.\",\n      \"evidence\": \"Cotransfection binding assay with 42 Rab proteins, site-directed mutagenesis, chimeric analysis\",\n      \"pmids\": [\"12578829\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No crystal structure of RIM2-RBD·Rab3A complex\", \"Functional consequence of Rab8A interaction uncharacterized\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"The 1.4 Å crystal structure of the RIM2 C2A domain revealed it does not bind Ca²⁺ and possesses a unique dipolar electrostatic surface, redefining it as a Ca²⁺-independent protein–protein interaction module rather than a classical Ca²⁺ sensor.\",\n      \"evidence\": \"X-ray crystallography, NMR spectroscopy, Ca²⁺-binding and protein-protein interaction assays\",\n      \"pmids\": [\"16216076\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological binding partners of the C2A bottom face not identified\", \"Whether C2B domain similarly lacks Ca²⁺ binding untested\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Demonstrating that short RIM2-RBD isoforms are recruited to dense-core vesicles via Rab3A and promote regulated secretion, while long isoforms with reduced Rab3A affinity do not, linked Rab3A-binding capacity directly to vesicle targeting and exocytosis.\",\n      \"evidence\": \"In vitro binding, subcellular localization in PC12 cells, neuropeptide Y secretion assay with binding-defective mutant\",\n      \"pmids\": [\"16473611\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of long-form autoinhibition not structurally resolved\", \"Whether isoform switching is physiologically regulated unknown\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Placing RIM2 within the GLP-1→cAMP→Epac2→RIM2→Rab3A cascade that enhances glucokinase activity extended its role beyond vesicle fusion to metabolic amplification of insulin secretion.\",\n      \"evidence\": \"RNAi knockdown of RIM2, Epac2, Rab3A in INS-1 and native β-cells with glucokinase activity and mitochondrial readouts\",\n      \"pmids\": [\"22147008\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism by which vesicle-associated RIM2 regulates cytoplasmic glucokinase unclear\", \"Single-lab finding not independently replicated\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Super-resolution imaging placed RIM2 inside the synaptic ribbon and CaV1.4 beneath it, and showed RIBEYE knockdown destabilizes RIM2, establishing the first spatial model of ribbon active zone architecture with RIM2 as an intermediary between RIBEYE and Ca²⁺ channels.\",\n      \"evidence\": \"STED microscopy and RIBEYE morpholino knockdown in zebrafish photoreceptors\",\n      \"pmids\": [\"22832038\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct binding interface between RIBEYE and RIM2 not mapped\", \"Whether this architecture is conserved across vertebrate ribbon synapses unknown\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Conditional double knockout of RIM1 and RIM2 at the calyx of Held quantitatively demonstrated their functional redundancy in maintaining presynaptic Ca²⁺ channel density and readily releasable pool size, establishing that neither isoform alone is essential at this synapse.\",\n      \"evidence\": \"Single and double conditional KO in mice with direct presynaptic patch-clamp electrophysiology at calyx of Held\",\n      \"pmids\": [\"25343783\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular mechanism of Ca²⁺ channel tethering by RIMs not resolved\", \"Whether redundancy holds at smaller CNS boutons untested\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Convergent studies in RIBEYE KO mice and human patients with biallelic RIMS2 loss-of-function variants established that RIBEYE stabilizes RIM2/CaV1.4 at photoreceptor active zones and that RIMS2 loss causes congenital cone-rod synaptic disorder with neurodevelopmental and metabolic phenotypes, validating its essential role in vivo across tissues.\",\n      \"evidence\": \"RIBEYE KO mice with quantitative immunostaining; human genetic study with biallelic variants, RIMS2 localization in human retina/cerebellum/islets, insulin secretion assay with truncated RIMS2\",\n      \"pmids\": [\"32249787\", \"32470375\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Genotype–phenotype correlation across different RIMS2 variants limited\", \"Whether partial loss-of-function alleles cause milder disease unknown\", \"Rescue experiments not performed\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"RBM5 was identified as a trans-acting regulator of RIMS2 splicing and protein homeostasis, revealing a new upstream layer controlling RIMS2 isoform diversity in brain.\",\n      \"evidence\": \"Conditional RBM5 KO in mice with immunoprecipitation and western blot analysis of RIMS2 variants\",\n      \"pmids\": [\"38218585\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Direct splicing mechanism and target exons not validated\", \"Not independently confirmed\", \"Functional consequence of the novel ~170 kDa RIMS2 variant unknown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the structural basis of RIM2 interactions with RIBEYE and Ca²⁺ channels, the mechanism by which the C2A domain's electrostatic surface recruits specific partners, and whether distinct RIMS2 splice variants serve non-redundant roles at different synapse types.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No structure of RIM2 in complex with RIBEYE or CaV channels\", \"C2A physiological partners unidentified\", \"Isoform-specific functions at distinct synapse types not dissected\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [0, 1, 2, 4, 8]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [4, 7]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [4]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [4]}\n    ],\n    \"complexes\": [\n      \"cAMP-GEFII (Epac2)·RIM2·Piccolo complex\"\n    ],\n    \"partners\": [\n      \"RAPGEF4\",\n      \"PCLO\",\n      \"RAB3A\",\n      \"RAB8A\",\n      \"RIBEYE\",\n      \"CACNA1F\",\n      \"RIM1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\nWait, I need to correct the pathway entries. The pathway slot should use Reactome IDs, not GO IDs. Let me fix:\n\n```json\n{\n  \"mechanistic_narrative\": \"RIMS2 is a presynaptic active zone scaffolding protein that functions as a Rab3A effector to regulate Ca²⁺-dependent exocytosis at both neuronal synapses and neuroendocrine secretory sites. Its N-terminal Rab-binding domain recognizes Rab3A through a critical acidic cluster (Glu-50/51/52), and its C2A domain adopts a Ca²⁺-independent β-sandwich fold with a dipolar electrostatic surface mediating protein–protein interactions [PMID:12578829, PMID:16216076]. In pancreatic β-cells, RIMS2 forms a cAMP-GEFII (Epac2)·RIM2·Piccolo complex that mediates cAMP-dependent, PKA-independent insulin secretion potentiated by incretins, with Piccolo serving as the Ca²⁺ sensor [PMID:11598134, PMID:12401793]. At neuronal synapses, RIMS2 redundantly controls presynaptic Ca²⁺ channel density and readily releasable pool size with RIM1, and at photoreceptor ribbon synapses it is stabilized by RIBEYE to organize CaV1.4 channel clusters; biallelic loss-of-function RIMS2 variants cause a syndromic congenital cone-rod synaptic disorder with neurodevelopmental impairment and abnormal glucose homeostasis [PMID:25343783, PMID:32249787, PMID:32470375].\",\n  \"teleology\": [\n    {\n      \"year\": 2001,\n      \"claim\": \"The discovery that cAMP-GEFII (Epac2) partners with RIM2 to drive PKA-independent exocytosis in β-cells established the first signaling pathway through which RIM2 acts, revealing it as a functional node in incretin-potentiated insulin secretion.\",\n      \"evidence\": \"Antisense knockdown of cAMP-GEFII in pancreatic islets combined with PKA inhibition, reconstituted exocytosis system\",\n      \"pmids\": [\"11598134\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct binding interface between Epac2 and RIM2 not mapped\", \"Contribution of individual RIM2 domains to this pathway unknown\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Identification of the trimeric cAMP-GEFII·RIM2·Piccolo complex, with Piccolo as Ca²⁺ sensor, resolved how Ca²⁺ sensitivity is conferred on a cAMP-driven exocytotic pathway lacking direct Ca²⁺ binding by RIM2 itself.\",\n      \"evidence\": \"Co-immunoprecipitation, dimerization assays, antisense knockdown of Piccolo in pancreatic islets\",\n      \"pmids\": [\"12401793\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry and assembly order of the tripartite complex undefined\", \"Whether this complex operates at neuronal synapses unknown\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Systematic Rab-specificity mapping and mutagenesis of the RIM2 RBD identified Glu-50/51/52 as critical for Rab3A recognition and showed RIM2 differs from RIM1 in not binding Rab27A, establishing isoform-specific effector selectivity.\",\n      \"evidence\": \"Cotransfection binding assay with 42 Rab proteins, site-directed mutagenesis, chimeric analysis\",\n      \"pmids\": [\"12578829\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No crystal structure of RIM2-RBD·Rab3A complex\", \"Functional consequence of Rab8A interaction uncharacterized\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"The 1.4 Å crystal structure of the RIM2 C2A domain revealed it does not bind Ca²⁺ and possesses a unique dipolar electrostatic surface, redefining it as a Ca²⁺-independent protein–protein interaction module rather than a classical Ca²⁺ sensor.\",\n      \"evidence\": \"X-ray crystallography, NMR spectroscopy, Ca²⁺-binding and protein-protein interaction assays\",\n      \"pmids\": [\"16216076\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological binding partners of the C2A bottom face not identified\", \"Whether C2B domain similarly lacks Ca²⁺ binding untested\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Demonstrating that short RIM2-RBD isoforms are recruited to dense-core vesicles via Rab3A and promote regulated secretion, while long isoforms with reduced Rab3A affinity do not, linked Rab3A-binding capacity directly to vesicle targeting and exocytosis.\",\n      \"evidence\": \"In vitro binding, subcellular localization in PC12 cells, neuropeptide Y secretion assay with binding-defective mutant\",\n      \"pmids\": [\"16473611\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of long-form autoinhibition not structurally resolved\", \"Whether isoform switching is physiologically regulated unknown\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Placing RIM2 within the GLP-1→cAMP→Epac2→RIM2→Rab3A cascade that enhances glucokinase activity extended its role beyond vesicle fusion to metabolic amplification of insulin secretion.\",\n      \"evidence\": \"RNAi knockdown of RIM2, Epac2, Rab3A in INS-1 and native β-cells with glucokinase activity and mitochondrial readouts\",\n      \"pmids\": [\"22147008\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism by which vesicle-associated RIM2 regulates cytoplasmic glucokinase unclear\", \"Single-lab finding not independently replicated\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Super-resolution imaging placed RIM2 inside the synaptic ribbon and CaV1.4 beneath it, and showed RIBEYE knockdown destabilizes RIM2, establishing the first spatial model of ribbon active zone architecture with RIM2 as an intermediary between RIBEYE and Ca²⁺ channels.\",\n      \"evidence\": \"STED microscopy and RIBEYE morpholino knockdown in zebrafish photoreceptors\",\n      \"pmids\": [\"22832038\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct binding interface between RIBEYE and RIM2 not mapped\", \"Whether this architecture is conserved across vertebrate ribbon synapses unknown\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Conditional double knockout of RIM1 and RIM2 at the calyx of Held quantitatively demonstrated their functional redundancy in maintaining presynaptic Ca²⁺ channel density and readily releasable pool size, establishing that neither isoform alone is essential at this synapse.\",\n      \"evidence\": \"Single and double conditional KO in mice with direct presynaptic patch-clamp electrophysiology at calyx of Held\",\n      \"pmids\": [\"25343783\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular mechanism of Ca²⁺ channel tethering by RIMs not resolved\", \"Whether redundancy holds at smaller CNS boutons untested\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Convergent studies in RIBEYE KO mice and human patients with biallelic RIMS2 loss-of-function variants established that RIBEYE stabilizes RIM2/CaV1.4 at photoreceptor active zones and that RIMS2 loss causes congenital cone-rod synaptic disorder with neurodevelopmental and metabolic phenotypes, validating its essential role in vivo across tissues.\",\n      \"evidence\": \"RIBEYE KO mice with quantitative immunostaining; human genetic study with biallelic variants, RIMS2 localization in human retina/cerebellum/islets, insulin secretion assay with truncated RIMS2\",\n      \"pmids\": [\"32249787\", \"32470375\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Genotype–phenotype correlation across different RIMS2 variants limited\", \"Whether partial loss-of-function alleles cause milder disease unknown\", \"Rescue experiments not performed\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"RBM5 was identified as a trans-acting regulator of RIMS2 splicing and protein homeostasis, revealing a new upstream layer controlling RIMS2 isoform diversity in brain.\",\n      \"evidence\": \"Conditional RBM5 KO in mice with immunoprecipitation and western blot analysis of RIMS2 variants\",\n      \"pmids\": [\"38218585\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Direct splicing mechanism and target exons not validated\", \"Not independently confirmed\", \"Functional consequence of the novel ~170 kDa RIMS2 variant unknown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the structural basis of RIM2 interactions with RIBEYE and Ca²⁺ channels, the mechanism by which the C2A domain's electrostatic surface recruits specific partners, and whether distinct RIMS2 splice variants serve non-redundant roles at different synapse types.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No structure of RIM2 in complex with RIBEYE or CaV channels\", \"C2A physiological partners unidentified\", \"Isoform-specific functions at distinct synapse types not dissected\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [0, 1, 2, 4, 8]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [4, 7]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [4]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 1, 6]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [7, 8, 10]},\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [0, 1, 4]}\n    ],\n    \"complexes\": [\n      \"cAMP-GEFII (Epac2)·RIM2·Piccolo complex\"\n    ],\n    \"partners\": [\n      \"RAPGEF4\",\n      \"PCLO\",\n      \"RAB3A\",\n      \"RAB8A\",\n      \"RIBEYE\",\n      \"CACNA1F\",\n      \"RIM1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}